Theravance Biopharma (TBPH) Property, Plant & Equipment (Net) (2013 - 2026)

Theravance Biopharma (TBPH) Property, Plant & Equipment (Net) (2013 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Property, Plant & Equipment (Net) (Qtr)
1	Oculis Holding AG	65,538.84 Bn	65,538.56 Bn	-	642,333.36
2	Nanobiotix	1,912.79 Bn	1,912.72 Bn	-	5.32 Mn
3	Akari Therapeutics	1,009.43 Bn	1,009.43 Bn	-	-
4	BeOne Medicines	469.46 Bn	464.67 Bn	1.35 Bn	1.64 Bn
5	Vertex Pharmaceuticals	122.69 Bn	115.45 Bn	2.59 Bn	1.61 Bn
6	Regeneron Pharmaceuticals	70.41 Bn	61.65 Bn	3.31 Bn	5.27 Bn
7	Belite Bio	62.84 Bn	62.84 Bn	-	-
8	Argenx Se	56.10 Bn	50.91 Bn	1.41 Bn	1.96 Bn
9	Alnylam Pharmaceuticals	37.48 Bn	34.47 Bn	959.66 Mn	518.26 Mn
10	Theravance Biopharma	866.36 Mn	471.69 Mn	-	5.54 Mn

Download Data